Albireo Pharma logo
Albireo Pharma ALBO

Quartalsbericht 2022-Q3
hinzugefügt 08.11.2022

report update icon

Albireo Pharma DSO 2011-2026 | ALBO

DSO Jährlich Albireo Pharma

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
14.7 - - 83.5 265 K - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
265 K 14.7 88.4 K

DSO Vierteljährlich Albireo Pharma

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 18 17.4 30.4 - 16.3 - - - - - - - - - - - - - - - 251 45.6 - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
251 16.3 63.1

DSO anderer Aktien in der Pharmaeinzelhändler

Name DSO Preis % 24h Marktkapitalisierung Land
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
16.2 K $ 3.5 -5.79 % $ 8.42 B australiaAustralia
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
70.9 $ 20.22 -0.76 % $ 945 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
48.3 - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
222 - - $ 86.2 M usaUSA
Advaxis Advaxis
ADXS
88.1 - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
Akebia Therapeutics Akebia Therapeutics
AKBA
62.9 $ 1.39 -0.43 % $ 357 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
0.114 - - $ 26.5 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 2.99 2.4 % $ 4.92 M israelIsrael
Aquestive Therapeutics Aquestive Therapeutics
AQST
103 $ 4.13 1.23 % $ 442 M usaUSA
Aravive Aravive
ARAV
16.8 - -13.39 % $ 1.45 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
106 $ 24.23 0.08 % $ 3.08 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
321 $ 32.58 1.05 % $ 2.16 B usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.5 0.34 % $ 399 M britainBritain
Cidara Therapeutics Cidara Therapeutics
CDTX
2.26 K - - $ 1.41 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
150 $ 2.55 - $ 16 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
BeiGene, Ltd. BeiGene, Ltd.
BGNE
52.6 - 0.49 % $ 251 B cayman-islandsCayman-islands
Baudax Bio Baudax Bio
BXRX
126 - 0.59 % $ 63 K usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
154 - - $ 2.17 B usaUSA
CymaBay Therapeutics CymaBay Therapeutics
CBAY
182 - - $ 3.45 B usaUSA